What's new

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised

Mar 14, 2025 - 09:39
 0
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised
Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Date of authorisation: 10/06/2015, Revision: 25, Status: Authorised
Read More

Tags:

Previous Article

Statement Oliver Zipse, Chairman of the Board of Management of BMW AG, Annual Co...

Next Article

Postpone Interfacial Impoverishment of Zn‐Ions via Neodymium‐Based Conversion Fi...

Related Posts

Herbal medicinal product: Valerianae aetheroleumArray, F: Assessment finalised

Herbal medicinal product: Valerianae aetheroleumArray, ...

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Imraldi, adalimumab, Date of authorisation: 24/08/2017, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 13, 2025  0

Human medicines European public assessment report (EPAR): Remicade, infliximab, Date of authorisation: 13/08/1999, Revision: 67, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0